AI assistant
ProPhase Labs, Inc. — Director's Dealing 2022
Jul 5, 2022
34999_dirs_2022-07-05_88cee6f2-e3b7-4d30-b58c-78d0fbf4a58e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2022-07-01
Reporting Person: Barr Jason Michael (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-07-01 | Option (right to buy) | $12.92 | A | 40000 | Acquired | 2029-07-01 | Common Stock (40000) | Direct |
Footnotes
F1: The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with such option vesting in four equal quarterly installments over one year, with the first quarterly installment to vest on September 30, 2022 and each additional installment to vest quarterly thereafter, provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of July 1, 2022.